GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CKD Bio Corp (XKRX:063160) » Definitions » Net Margin %

CKD Bio (XKRX:063160) Net Margin % : -23.03% (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is CKD Bio Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. CKD Bio's Net Income for the three months ended in Dec. 2023 was ₩-8,137 Mil. CKD Bio's Revenue for the three months ended in Dec. 2023 was ₩35,333 Mil. Therefore, CKD Bio's net margin for the quarter that ended in Dec. 2023 was -23.03%.

The historical rank and industry rank for CKD Bio's Net Margin % or its related term are showing as below:

XKRX:063160' s Net Margin % Range Over the Past 10 Years
Min: -15.09   Med: 5.61   Max: 8.94
Current: -15.09


XKRX:063160's Net Margin % is ranked worse than
71.25% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 3.53 vs XKRX:063160: -15.09

CKD Bio Net Margin % Historical Data

The historical data trend for CKD Bio's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CKD Bio Net Margin % Chart

CKD Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.94 4.98 -4.62 -10.70 -15.09

CKD Bio Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20.26 -6.65 -17.32 -15.11 -23.03

Competitive Comparison of CKD Bio's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, CKD Bio's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CKD Bio's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CKD Bio's Net Margin % distribution charts can be found below:

* The bar in red indicates where CKD Bio's Net Margin % falls into.



CKD Bio Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

CKD Bio's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-24192.52/160352.778
=-15.09 %

CKD Bio's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-8136.725/35332.99
=-23.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CKD Bio  (XKRX:063160) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


CKD Bio Net Margin % Related Terms

Thank you for viewing the detailed overview of CKD Bio's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


CKD Bio (XKRX:063160) Business Description

Traded in Other Exchanges
N/A
Address
368 Chungjeongno 3-ga, Seodaemun-gu, Seoul, KOR, 120-756
CKD Bio Corp is engaged in manufacturing and distribution of pharmaceutical materials and medicines. Its products portfolio include antibiotic, lactamase inhibitors, antituberculosis, antidiabetics, immunosuppressants, antihyperlipidemics, intermediates, and probiotics.

CKD Bio (XKRX:063160) Headlines

No Headlines